glp-1 mechanism of action animation Video: Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics: Nursing pharmacology Cardiovascular Protection with a Long-Acting

Conclusions These data demonstrate for the first time the potent effect of semaglutide in reducing voluntary alcohol intake in non-human primates and further substantiate the need for clinical trials investigating the effect of semaglutide in patients with alcohol-use disorder.

The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, with primary care, upfront pricing and doorstep delivery.

Potent gastric emptying delay is common with these medications, serving as a major contributor to the ...

California lawmakers are moving to cut Medicaid coverage for some expensive weight-loss drugs, such as Novo Nordisks Wegovy and Eli Lillys Zepbound, in a bid to reduce the states $12 billion budget deficit.

References: Abbass et al., AJO 2025

Semaglutide shows promise in reducing LDL cholesterol and triglycerides alongside weight loss